NFKB1 and prostate cancer: In highly metastatic prostate cancer, inflammatory factor CXCL1 activates the NF-κB signaling pathway, deacetylates histone H3 and H4, and down-regulates the expression of extracellular matrix glycoprotein fibulin-D1 (59).